Autres langues Resverlogix Corp.

Actions

RVX

CA76128M1086

Recherche biotechnologique et médicale

Temps Différé Toronto S.E. 21:52:04 16/09/2026			Varia. 5j.	Varia. 1 janv.
0,0900 ^CAD	0,00 %		0,00 %	-10,00 %

10/09	Resverlogix annonce la publication d'articles scientifiques portant sur la prévention de l'insuffisance cardiaque par l'apabetalone	CI
14/08	Resverlogix Corp. publie ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2026	CI

Autres langues

10/09	Resverlogix Announces Publication Of Scientific Journal Articles Relating To Apabetalone's Prevention Of Heart Failure
10/09	Resverlogix Announces Publication of Scientific Journal Articles Relating to Apabetalone's Prevention of Heart Failure
14/08	Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
26/06	Resverlogix Announces Voting Results from the 2026 Meeting of Shareholders
19/05	Resverlogix Closes US$2 Million Shares-for-Interest Private Placement
16/05	Resverlogix : Financial Statement Q1 2026
16/05	Resverlogix : MD&A Q1 2026
15/05	Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026
11/05	Resverlogix Corp. Announces One-Year Extension of USD 6.0 Million Secured Debenture with Shenzhen Hepalink Pharmaceutical Group Co., Ltd
11/05	Resverlogix Announces One-Year Extension of Debenture
16/04	Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO
11/04	Resverlogix Corp. Reports Earnings Results for the Full Year Ended December 31, 2025
11/04	Resverlogix : Annual Information Form 2025
11/04	Resverlogix : Financial Statement Q4 2025
10/04	Resverlogix Corp. Auditor Raises 'Going Concern' Doubt
02/04	Resverlogix Corp. Announces Issuance of MCTO by ASC
01/04	Resverlogix Corp. Provides Bi-Weekly MCTO Status Update
18/03	Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A
19/02	Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement
19/11	Resverlogix Appoints Bradley Glass to Board of Directors
18/11	Resverlogix Appoints Bradley Glass to Board of Directors
14/11	Resverlogix : MD&A Q3 2025
14/11	Resverlogix : Financial Statement September 30, 2025
14/11	Resverlogix Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
14/08/25	Resverlogix : MD&A Q2 2025